The Recovery Peptide Research Stack
TB-500 (thymosin beta-4) and BPC-157 are the two most complementary peptides in preclinical tissue repair research. Their non-overlapping mechanisms, combined with evidence of additive effects in multiple tissue models, make combined research designs scientifically compelling.
Why Combine TB-500 and BPC-157?
Mechanistic Complementarity
BPC-157 primary mechanisms:
- VEGF upregulation (local angiogenesis)
- eNOS/NO pathway (mucosal/vascular protection)
- Growth factor cascade (TGF-β, EGF, bFGF)
- GI-specific cytoprotection
TB-500 primary mechanisms:
- Actin sequestration → cell migration
- Systemic distribution for whole-body effects
- ILK/Akt survival signaling (cardiac)
- NF-κB anti-inflammation → M2 polarization
Complementary at every level:
- BPC: local VEGF → capillary budding
- TB: systemic cell migration → endothelial cell homing to new vessels
- BPC: initiates repair phase
- TB: resolves inflammatory phase systemically
Additive vs. Synergistic?
Current evidence suggests additive effects (independent pathways contributing separately). True synergy (>additive) has been proposed but requires dedicated combination RCTs to confirm.
Combined Study Design
Reconstitution
- BPC-157 10mg: Reconstitute in 5mL BAC water (2mg/mL)
- TB-500 10mg: Reconstitute in 5mL BAC water (2mg/mL)
- Keep separate — do not combine in one vial
- Administer at separate injection sites if subcutaneous
Rodent Dosing Reference
- BPC-157: 10 µg/kg i.p.
- TB-500: 100 µg/kg s.c. (different route practical for combination)
- Frequency: Once daily (most studies) to twice weekly
Control Arms for Combination Studies
- Vehicle only
- BPC-157 alone
- TB-500 alone
- BPC-157 + TB-500 combined
This 4-arm design allows interaction analysis and mechanistic attribution.
Recommended Models for Combined Research
- Muscle crush injury: Clean model, clear functional endpoints
- Tendon transection: Well-characterized individual compound data for comparison
- Wound healing: Straightforward, reproducible, easy endpoints
- Ischemia models: Cardiac or hindlimb for vascular applications
Sourcing for Research
our verified supplier provides both peptides as separate 10mg research-grade lyophilized vials, allowing consistent sourcing for multi-arm studies.
For laboratory research only. Not for human administration.